# ARIAN (NCT06431633)

> Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06431633
- Phase: PHASE3
- Status: RECRUITING
- Sponsor: Fundación GECP
- Conditions: Lung Diseases; Carcinoma, Non-Small-Cell Lung; Resectable Lung Non-Small Cell Carcinoma
- Interventions: Zimberelimab; Sacituzumab govitecan; Cisplatin; Carboplatin
- Enrollment: 129
- Primary outcome: Disease free survival

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=arian-nct06431633